Loading...
We would love for you to become a part of our community. Join our Discord to connect with us and other members!
- Ticker
- OSL.AU
- Price
- 0.01
- Stock movement up
- +- (%)
- Company name
- Oncosil Medical Ltd
- Exchange
- (AU ,
- Currency
- AUD )
- Sector
- Healthcare >Medical Devices
- Market cap
- 32.25M
- Ent value
- 29.73M
- Price/Sales
- 32.35
- Price/Book
- 6.81
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -0.72%
- 1 year return
- -17.65%
- 3 year return
- -45.18%
- 5 year return
- -45.90%
- 10 year return
- -21.65%
Last updated: 2025-01-04
DIVIDENDS
OSL.AU does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 32.35 |
| Price to Book | 6.81 |
| EV to Sales | 29.82 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 4.61B |
| EPS (TTM) | -0.01 |
| FCF per share (TTM) | -0.01 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 996.90K |
| Gross profit (TTM) | -9.26M |
| Operating income (TTM) | -22.04M |
| Net income (TTM) | -20.91M |
| EPS (TTM) | -0.01 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | -928.48% |
| Operating margin (TTM) | -2211.30% |
| Profit margin (TTM) | -2097.61% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 4.50M |
| Net receivables | 1.24M |
| Total current assets | 6.33M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 525.05K |
| Total assets | 6.72M |
| Accounts payable | 1.12M |
| Short/Current long term debt | 70.67K |
| Total current liabilities | 1.94M |
| Total liabilities | 1.98M |
| Shareholder's equity | 4.74M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -19.69M |
| Capital expenditures (TTM) | 278.85K |
| Free cash flow (TTM) | -19.97M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -441.50% |
| Return on Assets | -311.25% |
| Return on Invested Capital | -438.51% |
| Cash Return on Invested Capital | -418.75% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 0.01 |
| Daily high | 0.01 |
| Daily low | 0.01 |
| Daily Volume | 4.34M |
| All-time high | 0.26 |
| 1y analyst estimate | 0.06 |
| Beta | 0.94 |
| EPS (TTM) | -0.01 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | 26 Feb 2025 |
Downside potential
Loading...
Downside potential data
| OSL.AU | S&P500 | |
| Current price drop from All-time high | -97.25% | -2.61% |
| Highest price drop | -98.43% | -56.47% |
| Date of highest drop | 28 Jun 2024 | 9 Mar 2009 |
| Avg drop from high | -59.55% | -11.12% |
| Avg time to new high | 254 days | 12 days |
| Max time to new high | 2251 days | 1805 days |
COMPANY DETAILS
Marketcap
32.25M
Marketcap category
Small-cap
Description
OncoSil Medical Limited, a medical device company, develops and commercializes localized radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma in Australia, New Zealand, and Europe. Its lead product is OncoSil, a single-use brachytherapy device for the treatment of patients with locally advanced pancreatic cancer in combination with gemcitabine-based chemotherapy. OncoSil Medical Limited was incorporated in 2005 and is headquartered in Macquarie Park, Australia.
Employees
0
Website
Investor relations
-
SEC filings
CEO
Country
Australia
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found